Yield10 Bioscience Inc's Business Segments
Yield10 Bioscience Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Yield10 Bioscience Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Country - FY
- United States100%
Revenue by Geographic Country - FY
| Country | Revenue (Millions) | % of Total |
|---|---|---|
| United States | $ 0 | 100% |
Revenue by Product & Service Category - FY
- License100%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| License | $ 0 | 100% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Yield10 Bioscience Inc
Yield10 Bioscience specializes in utilizing its proprietary biotechnology platform to modify the metabolic pathways of various crops, such as canola, soybean, corn, and Camelina, to enhance their yield potential. By improving the productivity of these crops, the company aims to contribute to global food security and reduce the environmental impact of agriculture.
One of Yield10's key technologies is gene editing, where they modify the plant's genetic makeup to introduce desirable traits, such as increased oil content or improved photosynthetic efficiency. These genetic modifications are carried out using advanced molecular biology techniques, ensuring precise and targeted modifications without the use of foreign DNA.
The company also employs metabolic engineering techniques to optimize the plant's metabolic processes. Yield10's expertise lies in identifying key genes and enzymes involved in plant growth and development and subsequently modifying their expression patterns to enhance traits like biomass accumulation, seed yield, and stress tolerance. This approach allows for the development of crops that are more resilient to adverse environmental conditions, such as drought, heat, or salinity.
Yield10 Bioscience's product pipeline includes various genetically modified crops that have undergone rigorous testing and field trials to ensure their safety and efficacy. These products are intended to address specific agricultural challenges and market demands, such as high oleic soybeans for improved cooking oil quality, enhanced seed yield canola for biodiesel production, and high-protein corn for animal feed.
In addition to crop improvement, Yield10 is also actively involved in developing technologies for producing sustainable and eco-friendly bioplastics. By utilizing its metabolic engineering capabilities, the company aims to produce renewable and biodegradable polymers from non-food plant biomass, reducing the reliance on fossil fuels and minimizing the environmental impact associated with traditional plastics.
Yield10 Bioscience collaborates with academic institutions, government agencies, and commercial partners to advance its research and development efforts. The company also maintains a strong intellectual property portfolio, protecting its proprietary technologies and ensuring its competitive advantage in the market.
Overall, Yield10 Bioscience Inc. is a pioneering agricultural bioscience company that applies cutting-edge genetic and metabolic engineering techniques to improve crop productivity, reduce environmental impact, and address the global challenges of food security and sustainability.
